TransMedics Group, Inc. (TMDX) Q4 2019 Earnings Results

TransMedics Group, Inc. Misses on EPS — Stock Down 4.71%

TransMedics Group, Inc. reported a loss per share of $0.43, which contributed to a 4.71% decline in stock price following the earnings announcement. The lack of revenue figures and guidance may have raised concerns among investors about the company's near-term performance. Overall, the market reaction reflects uncertainty about the company's financial trajectory.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$-0.43	N/A	N/A
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Neutral

Management acknowledged the challenges faced in the quarter but emphasized their commitment to innovation. They did not provide detailed insights into future performance.

Management did not provide specific revenue figures or guidance for the upcoming quarters.

The focus remains on advancing their technology and market presence.

TransMedics Group, Inc. Misses on EPS — Stock Down 4.71%

Key numbers

Management commentary

TransMedics Group, Inc.

More earnings this week

TransMedics Group, Inc. Misses on EPS — Stock Down 4.71%

Key numbers

Management commentary